Get started Log in

NNMX — Nanomix Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
$0.00m
Enterprise Value
$11.46m
Revenue
$0.02m

Brief: Nanomix Partners With Mobility Health
02/09/2022 14:42
Brief: Nanomix Corp Enters Into Distribution Agreement With Bioasia Pte Ltd
23/08/2022 13:41
Brief: Nanomix announces ISO 134852016 certification for its new facility in San Leandro, CA
18/08/2022 13:34
Brief: Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger As CEO And Member Of The Board Of Directors
26/07/2022 14:31
Brief: Nanomix Completes 1-For-173 Reverse Stock Split
02/03/2022 12:25
Brief: Boston Therapeutics provides business update
07/02/2017 12:51
Brief: Boston therapeutics'affiliate's BTI-320 clinical trial reaches mid-point
08/07/2015 12:00
Brief: Boston Therapeutics and advance pharmaceutical expand agreement to market Sugardown(R) in 12 additional countries in Asia
21/11/2014 12:41